Clinical Trials
Re-induction with ADSTILADRIN resulted in complete responses in 31% of initial non-responders with Bacillus Calmette-Guérin (BCG)-unresponsive n...
May 19, 2026 | News
Positive Phase III readout of National Cancer Institute sponsored SWOG S1602 randomized clinical trial demonstrating non-inferior efficacy of the Tokyo...
May 19, 2026 | News
Approved for use before surgery based on DESTINY-Breast11 Phase III trial Approved for use following surgery based on DESTINY-Breast05 Phase III trial ...
May 19, 2026 | News
The German pharmaceutical company unifies its digital partner network, laying the foundation for AI-driven supply chain orchestration TraceLink, the world...
May 18, 2026 | News
SN BioScience Inc., a clinical-stage biotechnology company based in South Korea, announced today that it has initiated the first patient dosing in its...
May 18, 2026 | News
Akeso, Inc. announced that compelling results from its randomized, double-blind, placebo-controlled Phase II trial (AK117-206) of ligufalimab (AK117) will ...
May 18, 2026 | News
Safety Review Committee (SRC) gives Racura Oncology a recommendation to continue the Cardioprotection and Anticancer Synergy (CPACS) study in advanced soli...
May 18, 2026 | News
As compliance pressure mounts in every major healthcare AI market, Corti launches its Startup Acceleration Program to help founders clear a €600,000 r...
May 15, 2026 | News
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthc...
May 15, 2026 | News
Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico Me...
May 14, 2026 | News
Next-generation anti-CD19 CAR-T, Anbal-cel (CRC01), approval highlights Korean innovation Given the accelerating global momentum in CAR-T and gene th...
May 13, 2026 | News
Interim analyses show INBRX-106 + pembrolizumab achieved a 44.0% confirmed Objective Response Rate (cORR): In the prelimina...
May 13, 2026 | News
Landmark collaboration leverages complementary capabilities to drive speed in early innovation and help advance medicines for patients worldwide Agreement...
May 13, 2026 | News
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality med...
May 12, 2026 | News
Most Read
Bio Jobs
News
Editor Picks